These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25602514)

  • 1. Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR/PPARα and RXR/PPARγ interactions.
    Escudero P; Martinez de Marañón A; Collado A; Gonzalez-Navarro H; Hermenegildo C; Peiró C; Piqueras L; Sanz MJ
    Antioxid Redox Signal; 2015 Apr; 22(11):901-20. PubMed ID: 25602514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoid X receptor agonists impair arterial mononuclear cell recruitment through peroxisome proliferator-activated receptor-γ activation.
    Sanz MJ; Albertos F; Otero E; Juez M; Morcillo EJ; Piqueras L
    J Immunol; 2012 Jul; 189(1):411-24. PubMed ID: 22661092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II.
    Rius C; Piqueras L; González-Navarro H; Albertos F; Company C; López-Ginés C; Ludwig A; Blanes JI; Morcillo EJ; Sanz MJ
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):96-104. PubMed ID: 23117657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis.
    Escudero P; Navarro A; Ferrando C; Furio E; Gonzalez-Navarro H; Juez M; Sanz MJ; Piqueras L
    Br J Pharmacol; 2015 Jun; 172(12):2946-60. PubMed ID: 25630951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the retinoid X receptor modulates angiotensin II-induced smooth muscle gene expression and inflammation in vascular smooth muscle cells.
    Lehman AM; Montford JR; Horita H; Ostriker AC; Weiser-Evans MC; Nemenoff RA; Furgeson SB
    Mol Pharmacol; 2014 Nov; 86(5):570-9. PubMed ID: 25169989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration.
    Abu Nabah YN; Losada M; Estellés R; Mateo T; Company C; Piqueras L; Lopez-Gines C; Sarau H; Cortijo J; Morcillo EJ; Jose PJ; Sanz MJ
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2370-6. PubMed ID: 17717298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines.
    Mateo T; Abu Nabah YN; Abu Taha M; Mata M; Cerdá-Nicolás M; Proudfoot AE; Stahl RA; Issekutz AC; Cortijo J; Morcillo EJ; Jose PJ; Sanz MJ
    J Immunol; 2006 May; 176(9):5577-86. PubMed ID: 16622027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
    Li Y; Wang Q; Zhou J; Xu Q; Chu X; Sun T; Liu X; Cai S
    Eur J Pharmacol; 2014 Jan; 723():23-8. PubMed ID: 24333476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bexarotene, a Selective RXRα Agonist, Reverses Hypotension Associated with Inflammation and Tissue Injury in a Rat Model of Septic Shock.
    Tunctan B; Kucukkavruk SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S
    Inflammation; 2018 Feb; 41(1):337-355. PubMed ID: 29188497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
    Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
    J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
    Kang BY; Mehta JL
    J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin improves endothelial function in db/db mice: role of angiotensin II type 1 receptors and oxidative stress.
    Tian XY; Wong WT; Xu A; Chen ZY; Lu Y; Liu LM; Lee VW; Lau CW; Yao X; Huang Y
    Br J Pharmacol; 2011 Sep; 164(2b):598-606. PubMed ID: 21486274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium.
    Rius C; Company C; Piqueras L; Cerdá-Nicolás JM; González C; Servera E; Ludwig A; Morcillo EJ; Sanz MJ
    Thorax; 2013 Feb; 68(2):177-86. PubMed ID: 23143793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.
    van der Harst P; Groenewegen HC; Roks AJ; Buikema H; Zijlstra F; van Gilst WH; de Smet BJ
    Coron Artery Dis; 2008 Feb; 19(1):47-53. PubMed ID: 18281816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo imaging of leukocyte recruitment to the atheroprone femoral artery reveals anti-inflammatory effects of rosuvastatin.
    Osaka M; Hagita S; Yoshida M
    Biomed Res Int; 2013; 2013():962369. PubMed ID: 23509822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects and related mechanism of retinoid X receptor agonist bexarotene on atherosclerosis progression in diabetic apoE(-/-) mice].
    Zhu J; Xu C; Ning R; Chai D; Lin J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):492-7. PubMed ID: 25164224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin reduces platelet recruitment by inhibiting NADPH oxidase activation.
    Pignatelli P; Carnevale R; Di Santo S; Bartimoccia S; Nocella C; Vicario T; Loffredo L; Angelico F; Violi F
    Biochem Pharmacol; 2012 Dec; 84(12):1635-42. PubMed ID: 23022230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles.
    Mateo T; Naim Abu Nabah Y; Losada M; Estellés R; Company C; Bedrina B; Cerdá-Nicolás JM; Poole S; Jose PJ; Cortijo J; Morcillo EJ; Sanz MJ
    Blood; 2007 Sep; 110(6):1895-902. PubMed ID: 17595330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-NAME induces direct arteriolar leukocyte adhesion, which is mainly mediated by angiotensin-II.
    Nabah YN; Mateo T; Cerdá-Nicolás M; Alvarez A; Martinez M; Issekutz AC; Sanz MJ
    Microcirculation; 2005; 12(5):443-53. PubMed ID: 16020392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic vascular protective effects of combined low doses of PPARalpha and PPARgamma activators in angiotensin II-induced hypertension in rats.
    De Ciuceis C; Amiri F; Iglarz M; Cohn JS; Touyz RM; Schiffrin EL
    Br J Pharmacol; 2007 May; 151(1):45-53. PubMed ID: 17351653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.